SynthesisAfrican health sciences2024

Comparison of eptinezumab 300 mg with 100 mg for the treatment of migraine: a meta-analysis of randomized controlled studies.

Jing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.